CIK 0001513525 · Non-accelerated filer<br>Smaller reporting company
Azora Therapeutics, Inc. (DE)
Sign in to watch- Ticker
- AZR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800667150
- Phone
- 434-422-9800
- Business address
- 16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
- Former names
- ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-07-31 | Gilliland Robertson H. Director | Conversion | +29,931 | 95,424 | ||
| 2018-07-31 | Gilliland Robertson H. Director | Purchase | +14,000 | 109,424 | ||
| 2018-07-31 | Gilliland Robertson H. Director | Conversion · Convertible Note | −29,931 | 0 | ||
| 2018-07-31 | Gilliland Robertson H. Director | Conversion · Warrant to purchase common stock | +29,931 | 29,931 | ||
| 2018-07-31 | Gilliland Robertson H. Director | Purchase · Warrant to purchase common stock | +14,000 | 43,931 |
Page 12 of 12 · 225 trades